Mag One Closes Financing

Edited by Admin


For immediate release.

Mag One Closes Financing


MAG ONE PRODUCTS INC. (“Mag One” or the “Company”) announces that it has closed its financing of $1,000,000 at $0.90 per unit, subscribed for by Equitorial Exploration Corp. The units consist of one common share accompanied by one share purchase warrant at $1.10 for one year, subject tot an accelerated expiry period of 30 days upon a 30 day notification by
the Company that its shares have traded at $2.00 or more for 10 consecutive trading days. No finders fees or commissions will be paid for this financing.
Equitorial has now earned the exclusive right to joint venture with Mag One on a 50/50 basis to fund the construction of Mag One's first modular production facility for the extraction of magnesium and related products and the further non-exclusive right to joint venture with the Company to fund further modular production facilities.
As per our press release dated May 16, 2016, Mag one is developing Lithium extraction technology and has now granted Equitorial the exclusive right to enter into a joint venture with Mag One to fund, on a 50/50 basis, a Lithium extraction facility.

“Lucky Janda"
Chief Executive Officer company that aims to be the diamond standard in the magnesium (Mg) market by concentrating on four projects at its manufacturing plant site in southern Québec,Canada.


  1. Production of high-purity MgO, Silica and other saleable co-products, byproducts andcompounds.
  1. Production of 99.9% pure Mg ingots.
  2. Assembly and sale of magnesium oxide-based structural insulated sheathing panels.
  1. MagPower’s Mg-Air Fuel Cell for emergency power on sea and land.

Key advantages that these four projects share are Mag One’s advanced technologies, a modular processing plant expansion concept, and the Company’s easy access to tonnes of serpentinite tailings.

Signed: “Nelson M. Skalbania.”

CEO & Chairman

For further information or questions kindly contact the Company via email:

Mag One is listed on the CSE with the symbol, “MDD”, the Börse Frankfurt stock exchange (“Frankfurt”) with the ticker symbol “304” and the OTCQBwithtickersymbol"MGPRF”.Certainstatementscontainedinthisreleasemayconstitute"forward–lookingstatements"or"forward-looking information"(collectively"forward-lookinginformation")asthosetermsareusedinthePrivateSecuritiesLitigationReformActof1995andsimilar Canadian laws. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated”, “anticipates” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. This release contains forward-looking information relating to the business of the Company, the Property, financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof andthe Company is not obligated to update or revise any forward-looking information, whether because of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein. This news release does not constitute an offer of securities for sale in the United States. The Frankfurt Boerse, OTQ Markets Group Inc., CSE, or CNSX Markets have not reviewed this news release and does not accept responsibility for the adequacy or accuracy of the content of this news release. Issuers of news releases. are solely responsible for the accuracy of such news releases. For further information on risk, investors are advised to see the Companies MD&A and other disclosure filings with the CSE regulators which are found at

#145 - 925 Georgia Street West, Vancouver, BC V6C3L2 Canada

T:+1.604.669.4771 Fx: +1.604.669.4731 E: